Laboratories around the world invested billions in resources to support molecular testing for SARS-CoV-2, but the value of these tests will make a significant impact on global health beyond the pandemic. Molecular testing enables accurate and actionable results that can enhance the quality of patient care and shape the future for healthcare best practices.
While traditional methods, such as culture, continue to have an important role in diagnosis of infectious diseases, rapid PCR technology has clinical evidence to support improved patient outcomes. The technology is substantial, running thousands of highly sensitive samples with same day results.
Explore the resources below to learn more about the role molecular testing can serve in patient management and care decisions.
SARS-CoV-2: The importance of mutation testing and variant surveillance
Surveillance to detect mutations and variants is critical to supporting public health measures to combat SARS-CoV-2 and can directly impact treatment guidelines and recommendations. Learn how PCR genotyping can support early detection of new variants and quickly confirm viral mutation.
Respiratory
Molecular testing has improved diagnosis of circulating respiratory viruses and atypical bacteria.
Read more › | 6 min read
Influenza: An Underestimated Threat
Watch webinar › | 34 min watch
Antibiotic resistance
The growing threat of antibiotic resistance spurs new molecular technology that bears both advantages and disadvantages.
Read blog › | 9 min read
A Commentary and Perspective Take on Why Physicians Overprescribe Antimicrobials
Read blog › | 6 min read
Urinary
Discover how to use PCR for the detection of urinary tract infections and the growing evidence for this novel testing method.
Read blog › | 7 min read
Women’s health
From the detection of STIs to both commensal and pathogenic microbes, PCR delivers quick results from a single sample.
Watch webinar › | 76 min watch
The importance of distinguishing between aerobic vaginitis and bacterial vaginosis
It’s important to differentiate bacterial vaginosis (BV) from aerobic vaginitis (AV), an ongoing challenge with traditional methods. A molecular testing solution based on different bacterial combinations may allow distinction of BV versus AV, which has clinical significance with respect to treatment and care. This webinar presents a solution that could be employed to mitigate misdiagnosis of AV for BV.
Respiratory Tract Infections Learning Guide
Login required
The Respiratory Tract Infections Learning Guide serves three important functions for healthcare professionals:
- Foundational knowledge into viral, bacterial, fungal, and parasitic infections
- Best practices for how to test, diagnose, and surveil in the lab
- P.A.C.E. accreditation (in the United States)
Demystifying the development
and implementation of molecular
tests in a clinical laboratory
Learn more › | 5 min read
7 things to know before
establishing a molecular test
Learn more › | 3 min read
